ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2024; 14(3):1099-1100. doi:10.7150/thno.93248 This issue Cite
Erratum
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum
Henriette S. de Bruijn1 
, Vida Mashayekhi2, Tom J.L. Schreurs3, Pieter B.A.A. van Driel4, Gustav J. Strijkers5, Paul J. van Diest6, Clemens W.G.M. Lowik4, Ann L.B. Seynhaeve7, Timo L.M. ten Hagen7, Jeanine J. Prompers3, Paul M.P. van Bergen en Henegouwen2, Dominic J. Robinson1, Sabrina Oliveira2,8
1. Center for Optical Diagnostics and Therapy, Dept. of Otolaryngology and Head & Neck Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
2. Cell Biology Division, Dept. of Biology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
3. Biomedical NMR, Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
4. Division of Optical Molecular Imaging, Dept. of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
5. Amsterdam University Medical Centers, University of Amsterdam, Dept. of Biomedical Engineering and Physics, The Netherlands.
6. Dept. of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
7. Laboratory of Experimental Oncology, Dept. of Pathology, Erasmus MC, Rotterdam, The Netherlands.
8. Pharmaceutics Division, Dept. of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Citation:
de Bruijn HS, Mashayekhi V, Schreurs TJL, van Driel PBAA, Strijkers GJ, van Diest PJ, Lowik CWGM, Seynhaeve ALB, ten Hagen TLM, Prompers JJ, van Bergen en Henegouwen PMP, Robinson DJ, Oliveira S. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum. Theranostics 2024; 14(3):1099-1100. doi:10.7150/thno.93248. https://www.thno.org/v14p1099.htm
Other stylesCorrected-article in Theranostics, Volume 10, 2436
The authors regret to find an error in the published version of figure 1B, where the graph for 7D12-PS mistakenly was miscopied for 7D12-9G8-PS. During the review process a correct version of Figure 1B was included. The mistake was made while preparing the final text and figures in response to reviewers comments. The authors have revised Figure 1B, and confirm that the correction has no effect on the original data and conclusions. The authors apologize for any inconvenience that the errors may have caused.
Figure 1
(A) Example of intravital fluorescence images recorded of the tumor in the skin-fold chamber 1 h after administration of 7D12-PS or 7D12-9G8-PS. Bar is 200 µm. White arrows highlight fluorescence close to vessels that surround tumor tissue. (B) Fluorescence intensity in tumor (solid squares and lines) and normal tissue far from tumor and not showing GFP signal (open squares and dashed lines) in the skin-fold chamber after administration of physiological saline, 7D12-PS or 7D12-9G8-PS. Weighted mean ± SD, n=3, 6, 8 respectively. Significant differences between tumor and normal tissue with p<0.05 (*).
Author contact
Corresponding author: Henriette S. de Bruijn. Erasmus MC Cancer Institute, Center for Optical Diagnostics and Therapy, Dept. of Otolaryngology and Head & Neck Surgery, Room Ee1683. PO Box: 2040, 3000CA Rotterdam, The Netherlands. E-mail: h.debruijnnl.
Published 2024-1-9
Citation styles
APA
de Bruijn, H.S., Mashayekhi, V., Schreurs, T.J.L., van Driel, P.B.A.A., Strijkers, G.J., van Diest, P.J., Lowik, C.W.G.M., Seynhaeve, A.L.B., ten Hagen, T.L.M., Prompers, J.J., van Bergen en Henegouwen, P.M.P., Robinson, D.J., Oliveira, S. (2024). Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum. Theranostics, 14(3), 1099-1100. https://doi.org/10.7150/thno.93248.
ACS
de Bruijn, H.S.; Mashayekhi, V.; Schreurs, T.J.L.; van Driel, P.B.A.A.; Strijkers, G.J.; van Diest, P.J.; Lowik, C.W.G.M.; Seynhaeve, A.L.B.; ten Hagen, T.L.M.; Prompers, J.J.; van Bergen en Henegouwen, P.M.P.; Robinson, D.J.; Oliveira, S. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum. Theranostics 2024, 14 (3), 1099-1100. DOI: 10.7150/thno.93248.
NLM
de Bruijn HS, Mashayekhi V, Schreurs TJL, van Driel PBAA, Strijkers GJ, van Diest PJ, Lowik CWGM, Seynhaeve ALB, ten Hagen TLM, Prompers JJ, van Bergen en Henegouwen PMP, Robinson DJ, Oliveira S. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum. Theranostics 2024; 14(3):1099-1100. doi:10.7150/thno.93248. https://www.thno.org/v14p1099.htm
CSE
de Bruijn HS, Mashayekhi V, Schreurs TJL, van Driel PBAA, Strijkers GJ, van Diest PJ, Lowik CWGM, Seynhaeve ALB, ten Hagen TLM, Prompers JJ, van Bergen en Henegouwen PMP, Robinson DJ, Oliveira S. 2024. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum. Theranostics. 14(3):1099-1100.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.